Skip to main content
SPNT $23.72 +2.11%
SPNT logo

SPNT · SiriusPoint Ltd

Track SPNT — free
$23.72 +0.49 (+2.11%) At close · Aug 14
Market Cap
$2.76B
Shares
116.17M
All earnings calls

Earnings call · FY2025 Q4

SiriusPoint Ltd Q4 FY2025 Earnings Call

SiriusPoint Ltd Q4 FY2025 Earnings Call

Concluded Feb 19, 2026 Audio replay
Feb 19, 2026 54:24 26 turns
Period
FY2025 Q4
Runtime
54:24
Sources
5 artifacts

Executive readout · one minute

What matters this quarter

SiriusPoint closed 2025 with full-year gross written premium growth of 16%, an operating return on equity of 16.2% (above its 12–15% target), and operating EPS up 49% year-over-year. Q4 included an 18% premium increase, a 92.9% Core combined ratio, a $240m net income benefit from the $250m Armada sale, and announcements of a $100m share repurchase program and Series B Preference Share redemption that will take leverage to a historic low of 23%.

Underwriting performance and combined ratio 43 Insurance vs reinsurance mix 37 Accident & Health and IMG strategy 33 Capital deployment and balance sheet strength 25 Return on equity and book value growth 22 MGA partnerships and distribution 15

Management tone

Confident

Net tone +78 · low hedging

Grounding quotes
  • “We delivered a 49% increase in operating earnings per share over the prior year, and our leverage will reduce to an all-time low of 23% by the end of February.”
  • “Our 2025 operating return on equity of 16.2% has improved for the third consecutive year and, more importantly, outperformed against our 12% to 15% across the cycle target.”
  • “Our book value has increased by 28% in the year. That's added significant value for our shareholders. And we are positioned very well from a balance sheet perspective to take opportunities as they present themselves. So in summary, the future is bright for SiriusPoint.”
  • “We do recognize that insurance market conditions will be tougher in 2026, but it is also important to highlight that not in every market. We strongly believe our diversified portfolio and distribution focus on partnering with specialist MGAs positions us well to maintain our current levels of performance.”

Research coverage

5 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $973.70M +58.9% YoY
Net income · derived Q4 $244.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Full-year gross written premium up 16% and net written premiums up 19%, with Q4 gross and net written premiums both up 18%.
  • Full-year operating return on equity of 16.2%, third consecutive year of improvement and above the 12–15% across-the-cycle target; Q4 operating ROE of 17.1%.
  • Operating EPS up 49% to $2.55 for the full year; net income available to common shareholders of $444m ($3.64 diluted EPS).
  • Diluted book value per share grew 28% in 2025, with Q4 book value per diluted common share (ex. AOCI) up 9.9% to $18.10.
  • Full-year Core combined ratio of 91.7%; Q4 Core combined ratio of 92.9% despite historical one-offs in acquisition costs.
  • Closed sale of Armada MGA and announced sale of Arcadian MGA, crystallizing $390m of liquidity and ~$200m of off-balance sheet value; IMG now 100%-owned A&H MGA.

Risks & pressure points

  • Management acknowledged 2026 insurance market conditions will be tougher (though stated not in every market).
  • Q4 Core combined ratio of 92.9% was impacted by historical one-offs in acquisition costs.
  • GAAP net income in Q4 was flattered by the $250m Armada sale, driving a 44.9% annualized GAAP ROE that is not expected to repeat.
  • Year-end BSCR estimate of 247% drops to 232% pro forma post Series B redemption, indicating reduced capital buffer.

Key moments

Jump directly to management's words in the synchronized transcript.

“We do recognize that insurance market conditions will be tougher in 2026, but it is also important to highlight that not in every market. We strongly believe our diversified portfolio and distribution focus on partnering with specialist MGAs positions us well to maintain our current levels of performance.” Scott Egan, CEO
“Our overall capital remains strong, and our fourth quarter BSCR ratio has improved to 247%. Pro-forma for the upcoming Preferred Share Redemption, it is still a very healthy 232%. Our standard practice is to assess our capital position at the end of each year. And so today, we are pleased to be announcing our intention to repurchase $100 million of our outstanding common shares over the next 12 months.” Scott Egan, CEO
Full-screen source Call document